The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Davidson, Michael
One or more keywords matched the following items that are connected to Davidson, Michael
Item TypeName
Concept Hydroxymethylglutaryl-CoA Reductase Inhibitors
Academic Article Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
Academic Article Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.
Academic Article The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study.
Academic Article A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Academic Article Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.
Academic Article Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Academic Article A look to the future: new treatment guidelines and a perspective on statins.
Academic Article Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
Academic Article Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
Academic Article Management of hypercholesterolaemia in postmenopausal women.
Academic Article Combination therapy for dyslipidemia: safety and regulatory considerations.
Academic Article Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
Academic Article Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Academic Article Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
Academic Article A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
Academic Article Possible differences between fibrates in pharmacokinetic interactions with statins.
Academic Article Combination lipid-lowering therapy in diabetes.
Academic Article Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia.
Academic Article Comparative effects of lipid-lowering therapies.
Academic Article Lipid management and the elderly.
Academic Article Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
Academic Article Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.
Academic Article Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Academic Article Ezetimibe: a novel option for lowering cholesterol.
Academic Article Reducing residual risk for patients on statin therapy: the potential role of combination therapy.
Academic Article Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
Academic Article Striated muscle safety of ezetimibe/simvastatin (Vytorin).
Academic Article Statin safety: an assessment using an administrative claims database.
Academic Article Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
Academic Article Lipid-lowering effects of statins: a comparative review.
Academic Article Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Academic Article High-density lipoprotein metabolism: potential therapeutic targets.
Academic Article Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
Academic Article The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Academic Article Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals.
Academic Article Should every patient with diabetes receive a statin?
Academic Article The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
Academic Article Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
Academic Article A review of lipid management in primary and secondary prevention.
Academic Article Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Academic Article Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Academic Article Combination therapy in the management of complex dyslipidemias.
Academic Article Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
Academic Article The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Academic Article Treating dyslipidemia in high-risk patients: case reviews and discussion.
Academic Article Management of dyslipidemia in patients with complicated metabolic syndrome.
Academic Article Statin safety: an appraisal from the adverse event reporting system.
Academic Article Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Academic Article Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Academic Article Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
Academic Article Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
Academic Article Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Academic Article Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
Academic Article Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk.
Academic Article Safety of aggressive lipid management.
Academic Article The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.
Academic Article Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease.
Academic Article High-dose statin therapy: benefits and safety in aggressive lipid lowering.
Academic Article Statin and ezetimibe combination therapy in cardiovascular disease.
Academic Article Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence.
Academic Article High-dose statins in acute coronary syndromes.
Academic Article Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
Academic Article Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
Academic Article One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
Academic Article The use of high-sensitivity assays for C-reactive protein in clinical practice.
Academic Article Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
Academic Article Lp-PLA2: A new target for statin therapy.
Academic Article Pharmacokinetic interactions between statins and fibrates.
Academic Article Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu.
Academic Article Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.
Academic Article Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
Academic Article Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
Academic Article Apolipoprotein measurements: is more widespread use clinically indicated?
Academic Article Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Academic Article Apolipoprotein A-I therapy promise, challenges, and disappointment.
Academic Article The editor's roundtable: JUPITER follow-up.
Academic Article Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
Academic Article Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions.
Academic Article Risk for myopathy with statin therapy in high-risk patients.
Academic Article Newer pharmaceutical agents to treat lipid disorders.
Academic Article Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
Academic Article Torcetrapib/atorvastatin combination therapy.
Academic Article Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data.
Academic Article Rosuvastatin in elderly patients.
Academic Article Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
Academic Article Is it over for ezetimibe?
Academic Article Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
Academic Article Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
Academic Article A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Academic Article Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases.
Academic Article Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse uterine epithelial cells.
Academic Article Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
Academic Article Controversy surrounding the safety of cerivastatin.
Academic Article Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?
Academic Article Pharmacotherapy: Implications of high-dose statin link with incident diabetes.
Academic Article Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting.
Academic Article Cost effectiveness of treatment to National Cholesterol Education Panel (NCEP) targets with HMG-CoA reductase inhibitors. Trial design.
Academic Article Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
Academic Article Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.
Academic Article Combination therapy with statins: who benefits?
Academic Article Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
Academic Article Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
Academic Article A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
Academic Article Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.
Academic Article Overcoming toxicity and side-effects of lipid-lowering therapies.
Academic Article The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Academic Article Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
Academic Article Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Academic Article Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
Academic Article Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
Academic Article Changing characteristics of statin-related cIMT trials from 1988 to 2006.
Academic Article The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?
Academic Article Intensive statin therapy in India: Demonstrating efficacy and safety.
Academic Article Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
Academic Article Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.
Academic Article AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Academic Article Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
Academic Article Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
Academic Article Can We Cure Atherosclerosis?
Academic Article Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
Academic Article Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C.
Academic Article Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Academic Article Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.
Academic Article The Battle of the HDL Subfractions.
Academic Article Recent advances and emerging therapies in management of dyslipidemias.
Academic Article Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
Academic Article How I treat statin-associated side effects in an outpatient setting.
Academic Article Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Academic Article The clinical black, white, and gray lessons.
Academic Article Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial.
Academic Article Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
Academic Article Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
Academic Article Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN.
Academic Article Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.
Academic Article A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder.
Search Criteria
  • Hydroxymethylglutaryl CoA Reductase Inhibitors